Uncategorized
Astellas doesn’t pick up AviadoBio’s gene therapy, but nonprofit funding will move it forward
In a sign of the times for gene therapy, Astellas did not take up its option on AviadoBio’s frontotemporal dementia treatment, the UK biotech company disclosed on Tuesday. Instead, a clinical trial of the therapy …